IL1B and heart failure: Since Tet2 deficiency in macrophages results in overproduction of the pro-inflammatory and pro-atherogenic cytokine IL-1β [51], accelerated plaque growth, and increased risks of heart failure in mouse models [45], this raises the possibility that the blockade of IL-1β or its receptor may be effective therapy in individuals with TET2 mutations.